Log in to save to my catalogue

Expert Perspectives on Key Parameters that Impact Interpretation of Randomized Clinical Trials in Mo...

Expert Perspectives on Key Parameters that Impact Interpretation of Randomized Clinical Trials in Mo...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8776679

Expert Perspectives on Key Parameters that Impact Interpretation of Randomized Clinical Trials in Moderate-to-Severe Atopic Dermatitis

About this item

Full title

Expert Perspectives on Key Parameters that Impact Interpretation of Randomized Clinical Trials in Moderate-to-Severe Atopic Dermatitis

Publisher

Cham: Springer International Publishing

Journal title

American journal of clinical dermatology, 2022-01, Vol.23 (1), p.1-11

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

The recent advent of numerous clinical trials for the treatment of moderate-to-severe atopic dermatitis has led to new and emerging therapeutic options for this chronic inflammatory skin disease. With this rapid development has come a lack of consistency in study designs, trial conduct, and statistical analyses. Healthcare providers are challenged...

Alternative Titles

Full title

Expert Perspectives on Key Parameters that Impact Interpretation of Randomized Clinical Trials in Moderate-to-Severe Atopic Dermatitis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8776679

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8776679

Other Identifiers

ISSN

1175-0561

E-ISSN

1179-1888

DOI

10.1007/s40257-021-00639-y

How to access this item